The World In A Grain Of Sand

The World In A Grain Of Sand episodes:

• 05.29.2024

  The World in a Grain of Sand: CG Oncology

  KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss...

  
• 02.22.2024

  The World in a Grain of Sand: Verve Therapeutics

  KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Ketan Yerneni and Mack Healy discuss...

  
• 09.05.2023

  The World in a Grain of Sand: Schrödinger

  KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss...

  
• 04.19.2023

  The World in a Grain of Sand: Amylyx Pharmaceuticals

  KdT Ventures Partners, Mack Healy & Rima Chakrabarti take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This episode, Amylyx Pharmaceuticals, a neuro biotech founded...

  
• 03.08.2023

  The World in a Grain of Sand: Codiak BioSciences

  KdT Ventures Partners, Mack Healy & Phil Grayeski take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Codiak BioSciences.

  
• 01.24.2023

  The World in a Grain of Sand: Royalty Pharma

  KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Royalty Pharma.

  
• 10.07.2022

  The World in a Grain of Sand: Sana Biotechnology

  KdT Ventures Partners, Mack Healy & Phil Grayeski take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Sana Biotechnology.

  
• 06.30.2022

  The World in a Grain of Sand: Editas

  KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Editas.

  
• 05.17.2022

  The World in a Grain of Sand: Century Therapeutics

  KdT Ventures Partners, Mack Healy & Rima Chakrabarti take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Century Therapeutics.

  
• 03.04.2022

  The World In A Grain of Sand: Taysha

  The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Taysha GTx

  
• 09.27.2021

  The World In A Grain of Sand: Atai

  The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Atai

  
• 06.29.2021

  The World In A Grain of Sand: Recursion Pharmaceuticals

  The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Recursion Pharmaceuticals. 

  
• 05.04.2021

  The World In A Grain of Sand: AbCellera

  The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, AbCellera.